These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15716437)

  • 21. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
    Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
    J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the Mycobacterium ulcerans genome sequence reveals new loci for variable number tandem repeats (VNTR) typing.
    Hilty M; Käser M; Zinsstag J; Stinear T; Pluschke G
    Microbiology (Reading); 2007 May; 153(Pt 5):1483-1487. PubMed ID: 17464062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buruli ulcer and mycolactone-producing mycobacteria.
    Nakanaga K; Yotsu RR; Hoshino Y; Suzuki K; Makino M; Ishii N
    Jpn J Infect Dis; 2013; 66(2):83-8. PubMed ID: 23514902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mycolactone from a clinical isolate of Mycobacterium ulcerans provides evidence for additional toxin heterogeneity as a result of specific changes in the modular polyketide synthase.
    Hong H; Spencer JB; Porter JL; Leadlay PF; Stinear T
    Chembiochem; 2005 Apr; 6(4):643-8. PubMed ID: 15750996
    [No Abstract]   [Full Text] [Related]  

  • 27. Regulation of the 18 kDa heat shock protein in Mycobacterium ulcerans: an alpha-crystallin orthologue that promotes biofilm formation.
    Pidot SJ; Porter JL; Tobias NJ; Anderson J; Catmull D; Seemann T; Kidd S; Davies JK; Reynolds E; Dashper S; Stinear TP
    Mol Microbiol; 2010 Dec; 78(5):1216-31. PubMed ID: 21091506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing.
    Qi W; Käser M; Röltgen K; Yeboah-Manu D; Pluschke G
    PLoS Pathog; 2009 Sep; 5(9):e1000580. PubMed ID: 19806175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with
    Loglo AD; Frimpong M; Sarpong Duah M; Sarfo F; Sarpong FN; Agbavor B; Boakye-Appiah JK; Abass KM; Dongyele M; Frempong M; Pidot S; Wansbrough-Jones M; Stinear TP; Roupie V; Huygen K; Phillips RO
    PeerJ; 2018; 6():e5294. PubMed ID: 30090691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans.
    Käser M; Rondini S; Naegeli M; Stinear T; Portaels F; Certa U; Pluschke G
    BMC Evol Biol; 2007 Sep; 7():177. PubMed ID: 17900363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of genes on the Salmonella Virulence plasmid phylogeny revealed from sequencing of the virulence plasmids of S. enterica serotype Dublin and comparative analysis.
    Chu C; Feng Y; Chien AC; Hu S; Chu CH; Chiu CH
    Genomics; 2008 Nov; 92(5):339-43. PubMed ID: 18718522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of transfer-related regions of the vancomycin resistance Enterococcus conjugative plasmid pHTbeta: identification of oriT and a putative relaxase gene.
    Tomita H; Ike Y
    J Bacteriol; 2005 Nov; 187(22):7727-37. PubMed ID: 16267297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of plasmid diversity in 96 Rhodococcus equi strains isolated in Normandy (France) and sequencing of the 87-kb type I virulence plasmid.
    Duquesne F; Hébert L; Sévin C; Breuil MF; Tapprest J; Laugier C; Petry S
    FEMS Microbiol Lett; 2010 Oct; 311(1):76-81. PubMed ID: 20707817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With
    Röltgen K; Pluschke G
    Front Microbiol; 2020; 11():1018. PubMed ID: 32523571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent loss of immunogenic proteins in Mycobacterium ulcerans suggests immune evasion.
    Huber CA; Ruf MT; Pluschke G; Käser M
    Clin Vaccine Immunol; 2008 Apr; 15(4):598-606. PubMed ID: 18256209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis.
    Tafelmeyer P; Laurent C; Lenormand P; Rousselle JC; Marsollier L; Reysset G; Zhang R; Sickmann A; Stinear TP; Namane A; Cole ST
    Proteomics; 2008 Aug; 8(15):3124-38. PubMed ID: 18615429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples.
    Fyfe JA; Lavender CJ; Johnson PD; Globan M; Sievers A; Azuolas J; Stinear TP
    Appl Environ Microbiol; 2007 Aug; 73(15):4733-40. PubMed ID: 17526786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of Mycobacterium vanbaalenii as a model organism to study drug transporters of Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans: homology analysis of M. tuberculosis drug transporters among mycobacterial species.
    Gupta AK; Katoch VM; Chauhan DS; Lavania M
    Infect Genet Evol; 2012 Jun; 12(4):853-6. PubMed ID: 22127144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.